MedTrace Logo

MLPR As A Diagnostic Marker For Acute Pulmonary Embolism

NCT07023705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 37

Last updated 2025-06-19

No results posted yet for this study

Summary

A retrospective study to assess the utility of hematological marker (monocyte to large platelet ratio) to diagnose patients with pulmonary embolism

Conditions

  • Pulmonary Embolism (Diagnosis)
  • Diagnosis

Interventions

DIAGNOSTIC_TEST

Monocyte to Large Platelet Ratio (MLPR)

Admission laboratory values were used to calculate the Monocyte-to-Large Platelet Ratio (MLPR) by dividing the absolute monocyte count by the large platelet count. These values were obtained from blood samples collected before any treatment was administered.

Sponsors & Collaborators

  • Ain Shams University

    lead OTHER

Principal Investigators

  • Reem H Elkabarity, Professor · Ain Shams University

  • Hadil M Abdelhamid, Professor · Ain Shams University

  • Azza Lotfy, Professor · Ain Shams University

  • Mohamed k Awad, Lecturer · Ain Shams University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2024-12-31
Completion
2025-05-31

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07023705 on ClinicalTrials.gov